Home
ONC
ONC News

Latest BeiGene Ltd. American Depositary Shares (ONC) News on April 1, 2025

MT Newswires

a day ago

BeiGene Says EMA Panel Recommends Approval of Tevimbra for Lung Cancer

Driven Brands Holdings Among 3 Stocks Priced Below Estimated Fair Value

Simply Wall St.

a day ago

Driven Brands Holdings Among 3 Stocks Priced Below Estimated Fair Value

BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Business Wire

a day ago

BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

11 days ago

Exploring 3 High Growth Tech Stocks In The US Market

EXCLUSIVE: Indaptus Therapeutics Starts Phase 1 Combination Study of Decoy20 With BeiGene's Cancer Drug For Advanced Solid Tumors

Benzinga

14 days ago

EXCLUSIVE: Indaptus Therapeutics Starts Phase 1 Combination Study of Decoy20 With BeiGene's Cancer Drug For Advanced Solid Tumors

MT Newswires

a month ago

Beigene Insider Sold Shares Worth $2,073,826, According to a Recent SEC Filing

Thomson Reuters StreetEvents

a month ago

Q4 2024 Zymeworks Inc Earnings Call

MT Newswires

a month ago

Beigene Insider Sold Shares Worth $24,674,638, According to a Recent SEC Filing

FDA Approval For BeiGene (NasdaqGS:ONC) TEVIMBRA In ESCC Shows 34 Percent Death Risk Reduction

Simply Wall St.

a month ago

FDA Approval For BeiGene (NasdaqGS:ONC) TEVIMBRA In ESCC Shows 34 Percent Death Risk Reduction

FDA approves BeiGene’s Tevimbra plus chemo for oesophageal cancer

Pharmaceutical Technology

a month ago

FDA approves BeiGene’s Tevimbra plus chemo for oesophageal cancer

MT Newswires

a month ago

BeiGene Says FDA Approves Tevimbra for Esophageal Cancer First-Line Treatment

TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy

Business Wire

a month ago

TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy

MT Newswires

a month ago

Beigene Insider Sold Shares Worth $331,375, According to a Recent SEC Filing

Why BeiGene, Ltd. (ONC) is Skyrocketing So Far in 2025

Insider Monkey

a month ago

Why BeiGene, Ltd. (ONC) is Skyrocketing So Far in 2025

US$309 - That's What Analysts Think BeiGene, Ltd. (NASDAQ:ONC) Is Worth After These Results

Simply Wall St.

a month ago

US$309 - That's What Analysts Think BeiGene, Ltd. (NASDAQ:ONC) Is Worth After These Results

Is BeiGene, Ltd. (ONC) The Best Immunology Stock To Buy Now?

Insider Monkey

a month ago

Is BeiGene, Ltd. (ONC) The Best Immunology Stock To Buy Now?

BeiGene Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a month ago

BeiGene Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

BeiGene (ONC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a month ago

BeiGene (ONC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

MT Newswires

a month ago

Sector Update: Health Care Stocks Decline Premarket Thursday

MT Newswires

a month ago

BeiGene Ltd BeiGene Q4 Net Loss Narrows, Revenue Rises; 2025 Revenue Guidance Set

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Business Wire

a month ago

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

BeiGene to Present at Upcoming Investor Conferences

Business Wire

a month ago

BeiGene to Present at Upcoming Investor Conferences

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

Investor's Business Daily

a month ago

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

MT Newswires

a month ago

BeiGene Insider Sold Shares Worth $12,485,045, According to a Recent SEC Filing

US Stocks Trading Below Estimated Value In February 2025

Simply Wall St.

a month ago

US Stocks Trading Below Estimated Value In February 2025

BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?

Zacks

a month ago

BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?

High Growth Tech Stocks in the United States to Watch

Simply Wall St.

a month ago

High Growth Tech Stocks in the United States to Watch

HRMY or ONC: Which Is the Better Value Stock Right Now?

Zacks

a month ago

HRMY or ONC: Which Is the Better Value Stock Right Now?

BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27

Business Wire

2 months ago

BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27

Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:ONC) 41% Undervaluation?

Simply Wall St.

2 months ago

Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:ONC) 41% Undervaluation?

MT Newswires

2 months ago

Beigene Insider Sold Shares Worth $9,424,955, According to a Recent SEC Filing

ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo

Clinical Trials Arena

2 months ago

ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo

MT Newswires

2 months ago

ImmunityBio Partners With BeiGene to Conduct Phase 3 Trial of Lung Cancer Combination Therapy

Discover 3 US Stocks Including Microchip Technology That May Be Trading Below Estimated Fair Value

Simply Wall St.

2 months ago

Discover 3 US Stocks Including Microchip Technology That May Be Trading Below Estimated Fair Value

Exploring High Growth Tech Stocks in January 2025

Simply Wall St.

2 months ago

Exploring High Growth Tech Stocks in January 2025

When Can We Expect A Profit From BeiGene, Ltd. (NASDAQ:ONC)?

Simply Wall St.

2 months ago

When Can We Expect A Profit From BeiGene, Ltd. (NASDAQ:ONC)?

BeiGene Stock Meets 80-Plus RS Rating Benchmark

Investor's Business Daily

3 months ago

BeiGene Stock Meets 80-Plus RS Rating Benchmark

BeiGene (ONC) Moves 8.9% Higher: Will This Strength Last?

Zacks

3 months ago

BeiGene (ONC) Moves 8.9% Higher: Will This Strength Last?

MT Newswires

3 months ago

Beigene Insider Sold Shares Worth $7,370,515, According to a Recent SEC Filing

BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe

Business Wire

3 months ago

BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe

Share on Social Networks: